Results 91 to 100 of about 5,967 (167)

Sequential treatments with TRK inhibitors in a patient with NTRK fusion-positive sarcoma: A case report. [PDF]

Medicine (Baltimore), 2023
Kubota Y, Kawano M, Iwasaki T, Itonaga I, Tsumura H, Kaku N, Tanaka K.   +6 more
europepmc   +1 more source

Identification of NTRK fusion genes: experience in Mexico

Gaceta Mexicana de Oncolog�a, 2023
Leticia Bornstein-Quevedo, Claudia Bautista-Wong, Zaira Mojica-González, Mario Gámez-Rosales, Katia Hop-García   +4 more
openaire   +1 more source

Infant-Type Hemispheric Glioma With NTRK Fusion Responds to Larotrectinib. [PDF]

Cureus
Jain PV, Rumler S, North P.
europepmc   +1 more source

Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain Metastases. [PDF]

Cancer Res Commun
Contreras-Zárate MJ, Jaramillo-Gómez JA, Marquez-Ortiz RA, Pham TC, Koliavas SN, Ormond DR, Navarro AC, Nemenoff RA, Camidge DR, Cittelly DM.   +9 more
europepmc   +1 more source

Comparison of NTRK fusion detection methods in microsatellite-instability-high metastatic colorectal cancer. [PDF]

Virchows Arch, 2023
Schraa SJ, Stelloo E, Laclé MM, Swennenhuis JF, Brosens LAA, Fijneman RJA, Feitsma H, Koopman M, de Leng WW, Vink GR, Bol GM.   +10 more
europepmc   +1 more source

Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial. [PDF]

Nat Med
Besse B, Lin JJ, Bazhenova L, Goto K, de Langen AJ, Kim DW, Wolf J, Springfeld C, Popat S, Lim DWT, Nagasaka M, Hong JY, Baik CS, Hervieu A, Moreno V, Yang N, Kollengode K, Yang H, Xu Y, Calvet CY, Yuan Y, Hammell AB, Drilon A, Solomon BJ.   +23 more
europepmc   +1 more source

Larotrectinib in NTRK Fusion-Positive High-Grade Glioneuronal Tumor: A Case Report. [PDF]

Cureus, 2022
Tadipatri R, Eschbacher J, Fonkem E, Kresl J, Azadi A.   +4 more
europepmc   +1 more source

Cancer of Unknown Primary Most Suggestive of Colorectal Origin With Microsatellite Instability-high Status and High Tumor Mutation Burden Including NTRK Fusion. [PDF]

Cancer Diagn Progn
Sato H, Hiraki M, Shimonishi T, Takase Y, Komiya N, Nakashima C, Irie H, Akagi Y, Aragane N.   +8 more
europepmc   +1 more source

Neoadjuvant TRK inhibitors versus chemotherapy in advanced NTRK fusion-positive sarcomas: a real-world evidence analysis. [PDF]

Oncologist
Zhu F, Cheng H, Han Y, Yang S, Zhu Z, Ren Q, Su Y, Wang Z, Qin H, Yang W, Wang S, Gao Y, Wang H.   +12 more
europepmc   +1 more source

Response to entrectinib in a malignant glioneuronal tumor with ARHGEF2-NTRK fusion. [PDF]

Neurooncol Adv, 2022
Kurozumi K, Fujii K, Washio K, Ishida J, Otani Y, Sudo T, Tahara M, Ichimura K, Ennishi D, Date I.   +9 more
europepmc   +1 more source